B96.5
Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code B96.5 refers to infections caused by Pseudomonas aeruginosa and related bacteria, such as Pseudomallei and Mallei, when these pathogens are identified as the cause of diseases classified elsewhere. Pseudomonas aeruginosa is a common bacterium that can lead to various infections, particularly in individuals with compromised immune systems. Recognizing these infections and their implications is important for proper diagnosis and management.
Causes & Symptoms
Clinical Causes: Exposure to contaminated water, soil, or surfaces harboring Pseudomonas species Hospital-acquired infections, particularly in healthcare settings with invasive procedures or devices Weakened immune system due to conditions like cancer, HIV/AIDS, or chemotherapy Chronic lung diseases such as cystic fibrosis or bronchiectasis Use of immunosuppressive medications Existing wounds or burns which provide an entry point for bacteria
Key Symptoms: Respiratory issues such as cough, shortness of breath, and chest pain Skin infections including redness, swelling, and pus formation Ear infections presenting as pain, swelling, or discharge Urinary tract infections with symptoms like pain during urination and increased frequency Fever and chills indicating systemic infection Bloodstream infections that may cause sepsis in severe cases Ocular infections like conjunctivitis or keratitis
Diagnostic & Treatment
Diagnosis Path: The diagnosis of Pseudomonas-related infections typically involves collecting samples from infected areas—such as blood, sputum, urine, or wound swabs—and analyzing them through cultures. Laboratory identification of Pseudomonas aeruginosa, Mallei, or Pseudomallei confirms the causative agent. Additional tests like imaging studies or blood tests may be used to assess the extent of infection, especially in cases of suspected systemic involvement.
Treatment Protocols: Treatment strategies for infections caused by Pseudomonas species generally include targeted antibiotic therapy based on susceptibility patterns. Several antibiotics are effective, such as fluoroquinolones, aminoglycosides, piperacillin-tazobactam, and ceftazidime. Infections may require prolonged courses of antibiotics, especially in chronic or complicated cases. Supportive care and addressing any underlying conditions or immune deficiencies are also important components of management. Surgical intervention might be necessary for certain infections, such as abscess drainage or wound debridement.
Clinical Advice & FAQs
Billing Guidance
Is B96.5 a billable ICD-10 code?
Yes, B96.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B96.5?
Clinical documentation must specify the nature of Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
